VITEK® 2 Compact Gram Positive Card Gains International Approval for Food Safety Testing

02 May, 2012

bioMérieux VITEK® 2 Compact automated system for the identification of microorganisms, now has OMA approval for GN and GP cards

bioMérieux, a world leader in the field of in vitro diagnostics, today announced that the VITEK® 2 Compact now has AOAC® OMA (Official Methods of AnalysisSM) approval for the GP card (used to identify Gram-Positive bacteria), continuing a legacy of OMA approval for the VITEK automated methods. The VITEK GN card (used to identify Gram-Negative bacteria) received AOAC OMA approval last December. The VITEK® 2 Compact is the only automated system to receive OMA approval for the identification of Listeria and Staphylococcus species.

“The international approval for the VITEK 2 Compact Gram Positive Card further illustrates bioMérieux’s commitment to providing high quality testing solutions to our customers,” said Jean-Marc Durano, Corporate Vice President, Industrial Microbiology. “It’s another international recognition for the VITEK 2 Compact system that helps food industries manage their product safety.”

The VITEK 2 Compact was launched with the introduction of Advanced Colorimetric™ Technology, capable of barcoding for quality and full traceability from sample to result and an enhanced database. The VITEK 2 Compact system answers QC laboratory testing needs for fast and accurate microbial identification. The technology includes an expanded identification database, the most automated platform available, rapid results, improved confidence and minimal training time.

The full range of identification test cards includes the following:

  • GN card for Gram-negative bacilli
  • GP for Gram-positive cocci
  • BCL for Gram-positive spore forming bacilli
  • YST for yeast-like organisms
  • ANC for anaerobic bacteria
  • CBC for corynebacterium spp

About bioMérieux Food Safety

bioMérieux has been a global leader in providing innovative solutions to address food safety testing issues for more than 20 years. bioMérieux’s food safety focus encompasses prevention, detection, and quality assurance. The company offers extensive global resources and local expertise in microbiology control and food safety, driven by cutting-edge research and science to bring powerful new tools to the food industry. bioMérieux’s food testing solutions, including prepared culture media, instruments for sample and media preparation and filling, VIDAS®, TEMPO®, BacT/ALERT®, VITEK® 2 Compact and DiversiLab®, reflect its commitment to improving public health through a safe and nutritious food supply accessible globally. To learn more about food safety and quality solutions from bioMérieux, visit

About bioMérieux

Advancing Diagnostics to Improve Public Health

A world leader in the field of in vitro diagnostics for over 45 years, bioMérieux is present in more than 150 countries through 40 subsidiaries and a large network of distributors. In 2011, revenues reached €1.427 billion with 87% of sales outside of France.

bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases and providing high medical value results for cancer screening and monitoring and cardiovascular emergencies. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

bioMérieux is listed on the NYSE Euronext Paris market (Symbol: BIM – ISIN: FR0010096479).

Additional information can be found at

Media Contact

Media Relations

Paige Siwy
Tel +1 919-479-3638

Pioneering Diagnostics